GRACE CHEN: Open Payments
NPI 1003585597 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 65 payments from 11 companies in 2025. Trend: 2023 $680 · 2024 $860 · 2025 $1,283
Food & beverage: $1,052Education: $231
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $290 |
| ABBVIE INC. | 13 | $214 |
| GENZYME CORPORATION | 12 | $205 |
| Galderma Laboratories, L.P. | 16 | $158 |
| UCB, Inc. | 3 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $77 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $57 |
| LEO Pharma Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, Bimzelx, Rhapsido, RINVOQ, AKLIEF.
Industry payments across TX — which companies pay providers there.
